Lennie Ryer, Director at PharmAla Biotech Holdings, Inc., holds 36.00K shares in PharmAla Biotech Holdings, Inc. (Ticker: TSE:MDMA), holds 591.08K shares in Cannara Biotech (Ticker: LOVFF), holds 116.14K shares in SQI Diagnostics (Ticker: TSE:SQD.H). Most recently, Lennie Ryer Bought ― shares of PharmAla Biotech Holdings, Inc. on May 22, 2026 for an estimated value of C$5.40K.
Lennie Ryer latest transaction was an Informative Buy of C$5.40K.
What was Lennie Ryer's most profitable transaction?
Lennie Ryer’s most profitable transaction was an Informative Buy of TSE:MDMA stock on May 22, 2026. The return on the trade was 124.10%.
What is Lennie Ryer's role in PharmAla Biotech Holdings, Inc.?
Lennie Ryer's role in PharmAla Biotech Holdings, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.